CTOs on the Move

NextGate

www.nextgate.com

 
NextGate`s mission is to address the fundamental challenge of data management in the healthcare industry: the uncertainties and missed opportunities caused by duplicate and disconnected records in a data population. While implementing interface engine technology for hospitals in the early 1990s, we noticed a troubling trend – as application systems became integrated and exchanged data with each other, problems caused by duplicate and incomplete patient records (previously confined to one system and its MPI) multiplied and contaminated the data quality of other systems. Because this technical issue could impact a patient`s health, we made it our goal to find a solution. The ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nextgate.com
  • 3579 E. Foothill Blvd. Suite #587
    Pasadena, CA USA 91107
  • Phone: 626.376.4100

Executives

Name Title Contact Details
Greg Rumple
Chief Information Security Officer Profile

Similar Companies

Handbooks in Health Care Company

Handbooks in Health Care Company is a Newtown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monroe County Medical Center

Monroe County Medical Center is a Tompkinsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Petaluma Health Care District

Petaluma Health Care District is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DispatchHealth

DispatchHealth is redefining healthcare delivery through the most advanced on-demand, in-home healthcare model in the country. Our board-certified medical teams can treat common to complex injuries and illnesses in the comfort of your home.

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.